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A 16-year-old female spayed English Staffordshire terrier was presented for evaluation of a 10-month history of
intermittent myoclonic episodes, and a one weeks history of short episodes of altered mentation, ataxia and collapse.
Magnetic resonance imaging identified subcortical oedema, predominately in the parietal and temporal lobes
and multiple cerebral microbleeds.
Serum biochemistry, indirect blood pressure measurements and magnetic resonance imaging abnormalities were
consistent with hypertensive encephalopathy secondary to chronic kidney disease.
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Hypertension is a common sequel to chronic kidney dis-
ease (CKD), with the incidence of CKD associated systolic
arterial hypertension (SAP) in dogs estimated at around
30% [1]. Neurological complications of hypertension that
have been described in dogs and cats include cerebrovas-
cular disease and hypertensive encephalopathy [2-4].
In humans, hypertensive encephalopathy is defined as
a syndrome of neurological abnormalities including
seizures, secondary to hypertension induced cerebral
oedema [5,6]. This encephalopathy is now considered
part of posterior reversible encephalopathy syndrome
(PRES), a syndrome of clinical signs including headache,
altered mentation and vision abnormalities. The main
magnetic resonance imaging (MRI) abnormality is vaso-
genic oedema predominately affecting the occipital and
parietal white matter [5-8]. Cerebral oedema secondary
to hypertension induced PRES is reversible with anti-
hypertensive therapy. A recent veterinary case series has
described the MRI and clinicopathologic findings associ-
ated with hypertensive encephalopathy in 2 cats and 2
dogs [9]. These animals had MRI changes including oc-
cipital and parietal white matter oedema with concurrent
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unless otherwise stated.Cerebrovascular disease, and in particular intracerebral
haemorrhage, is found in up to 33% of people with PRES
[7]. Haemorrhage can be classified into 3 types; intrapar-
enchymal haematoma, small haemorrhages <5 mm diam-
eter and subarachnoid haemorrhage [5]. In people, the
small regions of haemorrhage/haemolysis which have
the imaging appearance of punctate signal voids on
T2*-weighted gradient recalled-echo sequences (T2*-GRE)
are termed cerebral microbleeds. These small, <5 mm
diameter lesions, correspond histopathologically to areas of
microhaemorrhage and/or products of haemolysis [10-13].
A veterinary case series has described the imaging charac-
teristics of cerebral microbleeds in 4 dogs; 1 dog of which
was found to be hypertensive [14].Case presentation
A 16-year old, female spayed, English Staffordshire terrier
was presented to the University of Melbourne Veterinary
Hospital for evaluation of episodes of myoclonic seizures
of 10 months duration. Exposure to bright sunlight or
quickly moving objects would result in generalized facial
twitching, tonic muscular contractions mainly affecting
the thoracic limbs, and an atonic phase with the dog fall-
ing backwards. The episodes had increased in frequency,
and at the time of presentation, the dog exhibited these
signs every few minutes when in full sunlight. Mentation
between events was normal. Five days prior to presenta-
tion, there were further neurological signs that were trig-
gered by a stressful event. This manifested as an episodeal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 T2-W sequence at the level of the medial geniculate,
showing a hyperintense signal in the internal capsule peripheral to
the lateral ventricles (arrows).
Figure 2 T2-W FLAIR sequence at the level of the interthalmic
adhesion showing a hyperintense signal in the internal capsule
peripheral to the lateral ventricles (arrows).
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and ataxia lasting a few minutes. This was followed by two
short episodes of ataxia and collapse without loss of con-
sciousness over the following week. The dog had a year
history of progressive polyuria and polydipsia.
The University of Melbourne Veterinary Research Board
approved the study.
Neurological examination was unremarkable aside from
generalized facial twitching and tonic muscular contrac-
tions elicited by visual stimulation such as a hand moving
quickly towards the dog. Fundic examination was normal.
The dog had a known, complete vaccination history, and
general physical examination was normal.
Results of a complete blood count, serum biochemistry
profile and urinalysis revealed abnormalities consistent
with chronic kidney disease. Serum urea nitrogen was
moderately elevated (19.8 mmol/L; reference interval (RI):
3.5 to 11.1 mmol/L), as was serum creatinine (206 mmol/L;
RI: 53 to 120 mmol/L). There was a mild normocytic
normochromic non-regenerative anaemia: haematocrit
36% (RI: 37 to 55%). Urine specific gravity (USG) was
1.020. Systolic arterial blood pressure (SAP) averaged
170 mmHg by Doppler sphygmomanometry [reference
limit (RL): <150 mmHg [2]]. Blood pressure readings
were taken 6 hours after hospitalisation and the average
of 5 readings over 20 minutes was recorded. Urine sedi-
ment was normal, as was urine protein-creatinine ratio
0f 0.15 (RL: <0.2). The dog was classified according to
the scoring system of the Internal Renal Interest Society
(IRIS 2009) as IRIS stage 3, non-proteinuric (NP), arterial
pressure (AP) sub stage 2. Abdominal ultrasonography
was unremarkable aside from a unilateral nephrolith with
associated chronic renal parenchymal changes. Thoracic
radiographs were not performed.
Magnetic resonance imaging of the brain was performed
using a 1.5 T magnet (GE Healthcare: Sigma HD). T1-
weighted (T1-W) 3D images were acquired pre and
post contrast in the dorsal plane and reformatted in
the transverse and sagittal planes. T2-weighted (T2-W)
images were acquired in transverse and sagittal planes,
fluid-attenuated inversion recovery (FLAIR) images were
acquired in the transverse plane, T2*-weighted gradient
recalled-echo (T2*-GRE) and diffusion-weighted images
(DWI) were acquired in the transverse plane, and ap-
parent diffusion coefficient (ADC) map in the transverse
plane was calculated (GE software: Functool). The con-
trast agent gadopetetate dimeglumine (MagnevistR, Bayer
Healthcare Pharmaceuticals) was administered intraven-
ously at a dose of 0.1 mmol/kg.
MR images showed a bilaterally symmetric T2-W and
FLAIR hyperintense signal predominately affecting the
white matter of the occipital and parietal lobes: tracking
along the internal capsule and extending into the corona
radiata peripheral to the lateral ventricles (Figures 1 and 2).The regions that were hyperintense on T2-W images were
isointense on DWI and hyperintense on the ADC map
(Figure 3). This was consistent with increased interstitial
water content found in vasogenic oedema [15-17].
T2*-GRE images showed 32 small (<2.5 mm diameter)
spherical lesions that were located in the cerebral hemi-
spheres predominantly at grey/white matter junctions in
the frontal, parietal, occipital and temporal lobes (Figure 4).
Figure 3 ADC Map at the level of the interthalmic adhesion
showing a hyperintense signal in the internal capsule (arrow).
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with a small number of lesions being isointense to hypoin-
tense to white matter on T1-W, T2-W and FLAIR images.
The lesions did not create a mass effect and there was
no evidence of perilesional parenchymal changes. There
was no contrast enhancement following gadolinium
administration.
The dog was treated with the anti-hypertensive agent
amlodipine besylate (Norvasc; Pfizer) at a dose of 2.5 mg
once daily, and levetiracetam (Levitiracetam; generic)Figure 4 T2*-GRE at the level of the caudate nucleus showing 5
punctate hypointense lesions at the grey/white matter junctions
(Arrows identify two lesions).250 mg every 8 hours. Myoclonic seizure activity responded
within 12 hours to the administration of levetiracetam. The
events decreased in frequency from every few minutes
when in bright sunlight, to once or twice daily. There were
no further episodes of altered mentation and collapse. Diet-
ary alterations were recommended, and the dog was started
on a commercial veterinary renal diet. At 9 months follow-
ing the initial diagnosis, repeat examination of the dog
showed infrequent myoclonic seizures. There were no
further signs of acute ataxia, vocalizing and collapse,
which were presumed to be secondary to hypertensive
encephalopathy. The dog had stable renal parameters
and was normotensive.
Conclusions
Hypertensive encephalopathy (HE) is a syndrome of
neurological abnormalities including seizure activity and
altered mentation secondary to hypertension. In people,
HE is considered part of PRES, and is characterized by
vasogenic oedema that predominately affects the occipi-
tal and parietal lobes. Vasogenic oedema is thought to
be secondary to a sudden elevation in blood pressure ex-
ceeding the autoregulatory capacity of the cerebral vas-
culature resulting in vessel wall injury and increased
permeability of the blood–brain barrier. Altered blood–
brain barrier permeability in conjunction with hyperper-
fusion allows the extravasation of fluid, macromolecules
and red blood cells into the parenchyma [5-8,18-20]. Risk
factors for the development of PRES in people include
abrupt arterial hypertension, renal dysfunction, pre-
eclampsia/eclampsia, immunosuppressive drugs, auto-
immune disorders and systemic infection [5-7,18,19].
In this case, the distinguishing MRI feature was of a
bilaterally symmetric T2-W and FLAIR hyperintense sig-
nal predominately affecting the subcortical white matter
including the internal capsule and corona radiata of the
occipital and parietal lobes. There was a lack of enhance-
ment following intravenous gadolinium administration.
DWI and ADC map changes were consistent with vaso-
genic oedema. Diffusion-weighted images are fundamen-
tal to the diagnosis of hypertensive encephalopathy, as it
allows differentials such as ischaemia to be eliminated.
Hypertensive encephalopathy secondary to CKD has
been described in the veterinary literature, although only
one study reports MRI abnormalities consistent with hyper-
tensive encephalopathy [9]. One animal in this study also
had a single lesion with imaging characteristics suggestive
of a cerebral microbleed. Pathologic findings in hyperten-
sive encephalopathy are well documented in the veterinary
literature. One study in dogs with CKD found that 3 of 14
(21%) dogs with averaged SAP values exceeding 180 mmHg
experienced seizure activity [1]. Two of the three dogs
had post mortem examination. One had findings consist-
ent with cerebrovascular disease, while the other dog had
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to cerebral oedema. Another case series documented
neurological abnormalities in 11 of 24 cats (46%) with
hypertension secondary to diseases including CKD and
hyperthyroidism. Two of these cats were subjected to
necropsy and both had multifocal cerebral arterioscler-
osis and focal regions of haemorrhage [21]. Cerebral
oedema secondary to hypertension has been documented
in cats secondary to reduced renal function or following
renal transplantation [3,22]. Histopathologic findings in-
clude generalized white matter oedema with separation of
the myelin sheaths by interstitial oedema [3].
Cerebrovascular disease, and in particular haemorrhage,
may occur in conjunction with PRES with 32% of people
in one study having microbleeds, hematomas or sub-
arachnoid haemorrhage [7]. Cerebral microbleeds (CMB)
in humans are secondary to amyloid angiopathy or from
hypertension-induced vascular changes to small cerebral
vessels [10-13]. As such they are considered to represent a
vasculopathy with the leaking of read blood cells across
the blood–brain barrier. Cerebral microbleeds can con-
tribute to cognitive dysfunction, however the main signifi-
cance of microbleeds in people is that they are considered
to indicate a future risk of infarction [23,24]. As in this
case, most CMBs in people are found distributed along
the grey-white matter interface or in the superficial cortex
[10]. On post-mortem examination, these focal areas adja-
cent to abnormal small vessels contain haemosiderin gran-
ules or haemosiderin containing macrophages/phagocytic
microglia [10-13]. Cerebral microbleeds have been de-
scribed in the veterinary literature although their signifi-
cance and aetiology has not been established [14,25].
Differentials for MRI findings suggestive of hyperten-
sive encephalopathy in this case would include a leukoen-
cephalopathy secondary to toxins, myelin deficiency,
leukodystrophy, or neurodegenerative diseases. The clin-
ical course of these disorders has been described in the lit-
erature and is not consistent with this case. The owner,
however, did not consent to further diagnostic tests in-
cluding cerebrospinal fluid sampling meaning that they
cannot be entirely excluded. The resolution of clinical
signs with amlodipine and levetiracetam, however, would
make them be considered much less likely. The dog in this
case report underwent MR imaging immediately following
frequent myoclonic activity. Post-ictal MRI changes
include reversible unilateral or bilateral temporal and
piriform lobe T2-weighted hyperintensities with varying
contrast enhancement [26]. The distribution of white mat-
ter oedema in the parietal and temporal lobes in this case,
was not considered to be characteristic of post-ictal MR
imaging abnormalities.
The reflex myoclonus in this dog was presumed to be
consistent with epilepsy: either primary, or secondary to
cerebral microbleeds or a neurodegenerative disorder.The acute deterioration was considered to be secondary
to hypertensive encephalopathy. Myoclonic seizures
are rare in dogs, and have most commonly been de-
scribed as a feature of Lafora disease and neuronal
ceroid-lipofuscinosis [27-29]. The dog in this case re-
port has been successfully medically managed with
levetiracetam and amlodipine for one year following
presentation making Lafora disease less likely. Lafora
disease has also been reported in the veterinary litera-
ture to result in the dilation of the lateral ventricles
secondary to cortical atrophy which was not a feature
in this case [27]. Neuronal ceroid-lipofuscinosis also has a
markedly different MR appearance with abnormalities
consistent with cerebral and cerebellar atrophy [30,31].
Levetiracetam was selected as the anticonvulsive agent as
it has been reported in people to be efficacious in the
treatment of progressive myoclonus epilepsy [32].
This report describes the magnetic resonance appear-
ance of hypertensive encephalopathy with concurrent
cerebral microbleeds. Limitations of this report include
the lack of a follow-up MRI to document resolution of
the white matter T2-weighted hyperintensities with med-
ical management. Future post-mortem analysis would also
be useful. Hypertensive encephalopathy should be consid-
ered when evaluating animals that have an acute onset
of neurological signs with concurrent systolic arterial
hypertension.
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